NASDAQ · Biotechnology

Instinct Bio Technical Co. Holdings Inc. (BIOT) Stock

$0.42 -2.82% NASDAQ: BIOT Healthcare

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Valuation

MetricValue
Price$0.42
Market Cap$1.79M
P/E Ratio-0.99
P/B Ratio-440724.54
P/S Ratio0.00
EPS (TTM)$-0.42
52-Week High$50.00
52-Week Low$0.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.95

Latest News

Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives NewMediaWire · Jul 30, 2026 BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets GlobeNewswire · Jul 29, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.10
FCF Yield-84.72%
Quick Ratio0.95
Interest Coverage-0.30
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held12.18%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Instinct Bio Technical Co. Holdings Inc.

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Instinct Bio Technical Co. Holdings Inc. is headquartered in US.

Instinct Bio Technical Co. Holdings Inc. (BIOT) stock trades at $0.42 with a market capitalization of $1.79M. The stock is valued at a price-to-earnings (P/E) ratio of -0.99, price-to-book of -440724.54, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.39 and $50.00, and currently trades 99.2% below its 52-week high.

On profitability, Instinct Bio Technical Co. Holdings Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: instinct-biot.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides